Meachem has become one of the most effective advocates in the ongoing battle against HIV by understanding the notion of differences — and acting boldly and unconventionally to transcend them.
Paul LeVine, VP, Analytic Services for TrialCard, describes proven strategies that prevent patient adherence fall off, driven by evidenced-based design and patient engagement programs.
Can the healthcare industry really expect to drive patient engagement?
With about 70 million users in six million health-related groups, drugmakers have tremendous opportunity to reach key audiences on Facebook. Here’s how.
How Excedrin brought VR to drug marketing with The Migraine Experience
While VR is only just getting started, some marketers are already embracing its potential to offer an immersive experience for far-off future campaigns.